Theranica develops non-invasive, drug-free, personalized wearable therapeutic products for the treatment of migraine, ages 12 and up, by integrating the latest neuroscience research with notable technological expertise. Theranica’s smartphone-controlled prescription migraine device, Nerivio®, was recognized in TIME Magazine's 2019 annual list of the 100 Best Inventions.